Cherokee Insurance’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$549K Hold
3,500
0.21% 81
2026
Q1
$535K Hold
3,500
0.2% 85
2025
Q4
$483K Hold
3,500
0.2% 83
2025
Q3
$449K Hold
3,500
0.19% 85
2025
Q2
$424K Hold
3,500
0.18% 88
2025
Q1
$390K Hold
3,500
0.17% 87
2024
Q4
$341K Buy
+3,500
New +$373K 0.15% 87

Other funds holding NVS

Cherokee Insurance's NVS Position: Q2 2026 in Review

Cherokee Insurance held its Novartis (NVS) position steady in Q2 2026 at 3,500 shares worth $549K. The position accounts for 0.21% of the portfolio, ranked #81.

Cherokee Insurance first reported a position in NVS in Q4 2024 and has held it in 7 quarters since. 828 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Cherokee Insurance held 3,500 shares of Novartis worth $549K as of Q2 2026.
  • Cherokee Insurance left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.21% of Cherokee Insurance's portfolio in Q2 2026, its #81 holding.
  • Cherokee Insurance first reported a position in Novartis in Q4 2024 and has held it in 7 quarters since.
  • 828 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Cherokee Insurance's 13F filing for Q2 2026, filed 3 Aug 2026.